We are live on ! Find out more
FBRX icon

Forte Biosciences
FBRX

61 hedge funds and large institutions have $51.5M invested in Forte Biosciences in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 18 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

41% more call options, than puts

Call options by funds: $768K | Put options by funds: $545K

5% more funds holding

Funds holding: 58 → 61 (+3)

0.01% less ownership

Funds ownership: 0.08% → 0.07% (-0.01%)

31% less capital invested

Capital invested by funds: $74.7M → $51.5M (-$23.2M)

33% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 18

Holders
61
Holders Change
+3
Holders Change %
+5.17%
% of All Funds
1.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
12
Reduced
18
Closed
3
Calls
$768K
Puts
$545K
Net Calls
+$223K
Net Calls Change
-$53K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$608K
2
6CM
683 Capital Management
New York
+$487K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$483K
4
State Street
State Street
Massachusetts
+$282K
5
JMPWA
JP Morgan Private Wealth Advisors
California
+$176K

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$4.62M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.69M
3
JP Morgan Chase
JP Morgan Chase
New York
-$1.88M
4
BI
BVF Inc
California
-$326K
5
BP
BBR Partners
New York
-$267K
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
26
Teachers Advisors
New York
$321K -$25.6K -7 -7%
TCIM
27
TIAA CREF Investment Management
New York
$294K -$51.3K -14 -14%
Wells Fargo
28
Wells Fargo
California
$288K -$47.6K -13 -14%
Charles Schwab
29
Charles Schwab
California
$280K – – –
AA
30
ALPS Advisors
Colorado
$270K +$22K +6 +8%
BP
31
BBR Partners
New York
$257K -$267K -73 -50%
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$257K – – –
Goldman Sachs
33
Goldman Sachs
New York
$235K +$117K +32 +91%
Millennium Management
34
Millennium Management
New York
$188K -$135K -37 -41%
JMPWA
35
JP Morgan Private Wealth Advisors
California
$170K +$176K +48 New
TD Asset Management
36
TD Asset Management
Ontario, Canada
$169K – – –
GJIC
37
Gamble Jones Investment Counsel
California
$162K – – –
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$161K – – –
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$154K +$14.6K +4 +10%
WJA
40
Williams Jones & Associates
New York
$145K -$22K -6 -13%
RJA
41
Raymond James & Associates
Florida
$142K +$146K +40 New
DAM
42
Doheny Asset Management
California
$126K -$14.6K -4 -10%
AIG
43
American International Group
New York
$108K +$3.66K +1 +3%
ProShare Advisors
44
ProShare Advisors
Maryland
$100K -$3.66K -1 -3%
SWP
45
Stratos Wealth Partners
Ohio
$98K – – –
UBS Group
46
UBS Group
Switzerland
$66K – – –
Bank of America
47
Bank of America
North Carolina
$49K +$33K +9 +180%
GT
48
Glenmede Trust
Pennsylvania
$47K – – –
LWCFA
49
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$27K – – –
Legal & General Group
50
Legal & General Group
United Kingdom
$21K -$7.32K -2 -25%
1
2
3

FBRX Hedge Fund Activity: Q2 2018 in Review

61 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q2 2018, worth a combined $51.5M — down 31% from $74.7M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new FBRX positions and 3 closed out — a net gain of 3 holders — while 12 added to existing stakes and 18 trimmed.

The largest buyer was BlackRock, adding an estimated $608K. The largest seller was T. Rowe Price Associates, cutting an estimated $4.62M.

  • 61 institutional investors held Forte Biosciences (FBRX) as of Q2 2018, up from 58 in Q1 2018.
  • Funds reported $51.5M of Forte Biosciences stock for Q2 2018, down 31% quarter-over-quarter.
  • 6 funds opened new Forte Biosciences positions in Q2 2018 and 3 closed out, a net change of +3 holders.
  • The largest Forte Biosciences buyer in Q2 2018 was BlackRock, an estimated $608K added.
  • The largest Forte Biosciences seller in Q2 2018 was T. Rowe Price Associates, an estimated $4.62M sold.

Based on aggregated 13F filings for Q2 2018.